An ongoing dialogue on HIV/AIDS, infectious diseases,
April 22nd, 2019
Two New Trials of Combination Therapy for MRSA Bacteremia Answer Some Questions — and Raise Several New Ones
Every clinically active ID specialist, hospitalist, and cardiologist realizes that treatment of bacteremia due to methicillin-resistant Staph aureus (MRSA) is no easy task. In fact, it’s a problem so difficult that persistent bacteremia due to MRSA deserved highlighting here as an “Unanswerable Problem in Infectious Diseases”. I wrote that over 5 years ago, and you know what? […]